Standard InChI: InChI=1S/C12H13N3O4.C2HF3O2/c13-6-7-1-3-8(4-2-7)14-12(19)15-9(11(17)18)5-10(15)16;3-2(4,5)1(6)7/h1-4,9H,5-6,13H2,(H,14,19)(H,17,18);(H,6,7)/t9-;/m0./s1
Standard InChI Key: MNDNLZYZPARUJP-FVGYRXGTSA-N
Associated Targets(Human)
Integrin alpha-5/beta-1 686 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-V/beta-3 2708 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-4/beta-1 2269 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SK-MEL-24 129 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MCF7 126967 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HT-29 80576 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
K562 73714 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HEL 6614 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-V/beta-5 589 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-V/beta-6 509 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-IIb/beta-3 3481 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Integrin alpha-L/beta-2 (LFA-1) 51 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 263.25
Molecular Weight (Monoisotopic): 263.0906
AlogP: 0.36
#Rotatable Bonds: 3
Polar Surface Area: 112.73
Molecular Species: ZWITTERION
HBA: 4
HBD: 3
#RO5 Violations: 0
HBA (Lipinski): 7
HBD (Lipinski): 4
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.03
CX Basic pKa: 9.25
CX LogP: -2.42
CX LogD: -2.42
Aromatic Rings: 1
Heavy Atoms: 19
QED Weighted: 0.68
Np Likeness Score: -0.54
References
1.Galletti P, Soldati R, Pori M, Durso M, Tolomelli A, Gentilucci L, Dattoli SD, Baiula M, Spampinato S, Giacomini D.. (2014) Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives., 83 [PMID:24973662][10.1016/j.ejmech.2014.06.041]
2.Martelli G, Baiula M, Caligiana A, Galletti P, Gentilucci L, Artali R, Spampinato S, Giacomini D.. (2019) Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?, 62 (22):[PMID:31670514][10.1021/acs.jmedchem.9b01000]
3.Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D. (2016) New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins., 59 (21):[PMID:27726366][10.1021/acs.jmedchem.6b00576]